Medical congresses provide among the most important opportunities for HCPs and drug and device developers to exchange learnings, share research, and advance their work while gathering insights to make smart business decisions. But such events are not without challenges. Discussions can get lost after the event, insights gleaned may not be accurate if not captured in the moment, and colleagues may not share information until months later. All of these factors can prolong timelines, negatively affecting product development processes. How can organizations begin modernizing medical congress insights management?
As more medical conferences explore a hybrid model that offers valuable in-person networking opportunities combined with the advantages of virtual, insights management strategies will modernize how life science organizations plan and execute congress attendance.
- Andrew Townsend, Senior Director, Hospital & Academic Institution Medical Engagement Lead at Pfizer
- Siobhan Mitchell, General Medicines Global Medical Office Head at Sanofi
- Robert Kersting, Worldwide Head, Scientific Alliances at Novartis Oncology
During the event, panelists discussed how virtual engagement and modern insights management helps ensure the democratization of scientific discussion, contributes to more effective post-congress communication, and enables life science teams to have more targeted interactions with the right experts to drive their strategy.